Literature DB >> 4083175

The effects of diosmin (a benzo-pyrone) upon some high-protein oedemas: lung contusion, and burn and lymphoedema of rat legs.

J R Casley-Smith, J R Casley-Smith.   

Abstract

Oral diosmin (a benzo-pyrone) was used to treat rats with contused lungs, in doses of 50 or 200 mg/kg/day. The contusion was produced by direct trauma. The lungs were examined with the electron microscope, both qualitatively and quantitatively, at 1, 2 and 4 days. It was found that diosmin considerably reduced interstitial oedema and tissue disorganization. The concentration of protein, both in the interstitial tissue and in the air spaces, was also much reduced. There was a greater effect at the higher dosage than at the lower one. In two other experiments, this drug was used in the usual models of burn oedema of the rat foot and acute lymphoedema of the rat leg - estimating the amount of oedema by weighing the parts. A low dose (50 mg/kg) reduced the burn oedema; a high dose (200 mg/kg) did not. Both doses reduced the acute lymphoedema of the whole leg, or thigh. The high dose did not do this in the foot, but the low one did. At high doses, diosmin has the usual benzo-pyrone property of releasing mediators in the rat-foot. In other tissues (and, no doubt, species) this drug reduces many forms of high-protein oedema, like the other benzo-pyrones.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4083175     DOI: 10.1007/BF01966674

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  14 in total

Review 1.  Morphological basis of alveolar-capillary gas exchange.

Authors:  E R Weibel
Journal:  Physiol Rev       Date:  1973-04       Impact factor: 37.312

Review 2.  The metabolism and biological actions of coumarins.

Authors:  G Feuer
Journal:  Prog Med Chem       Date:  1974

3.  Effects on tissue fine structure of variations in colloid osmotic pressure of glutaraldehyde fixatives.

Authors:  S O Bohman; A B Maunsbach
Journal:  J Ultrastruct Res       Date:  1970-01

4.  The structure of the interalveolar septum of the mammalian lung.

Authors:  S F Ryan
Journal:  Anat Rec       Date:  1969-12

5.  [Vitamin P and C2 activity of a flavone heteroside: diosmine].

Authors:  P Desnoyers; J Virgitti; F Rodier; M Clenet
Journal:  Therapie       Date:  1968 Nov-Dec       Impact factor: 2.070

6.  [Morphology and x-ray picture of the rat lung in experimental lung contusion].

Authors:  P Eckert; H Frommhold; M Doehn; K Riesner
Journal:  Langenbecks Arch Chir       Date:  1975

7.  Benzo-pyrones: their selective injury to rabbit vascular endothelium.

Authors:  N B Piller
Journal:  Clin Exp Pharmacol Physiol       Date:  1976 Mar-Apr       Impact factor: 2.557

8.  The effect of macrophage poisoning by silica on experimental pulmonary contusion and its benzo-pyrone treatment.

Authors:  J R Casley-Smith; P Eckert; E Földi-Börcsök; M Földi
Journal:  Br J Exp Pathol       Date:  1977-08

9.  Excess plasma proteins as a cause of chronic inflammation and lymphodema: quantitative electron microscopy.

Authors:  J R Casley-Smith; R M Gaffney
Journal:  J Pathol       Date:  1981-03       Impact factor: 7.996

10.  Effects of 5,6 benzo-alphapyrone on traumatic edema due to crush and burn injury.

Authors:  S H Miller; M Abell; D Buck; D Kress; T S Davis; R J DeMuth
Journal:  J Trauma       Date:  1981-05
View more
  4 in total

Review 1.  Rare adipose disorders (RADs) masquerading as obesity.

Authors:  Karen L Herbst
Journal:  Acta Pharmacol Sin       Date:  2012-02       Impact factor: 6.150

2.  Diosmin reduces cerebral Aβ levels, tau hyperphosphorylation, neuroinflammation, and cognitive impairment in the 3xTg-AD mice.

Authors:  Darrell Sawmiller; Ahsan Habib; Song Li; Donna Darlington; Huayan Hou; Jun Tian; R Douglas Shytle; Adam Smith; Brian Giunta; Takashi Mori; Jun Tan
Journal:  J Neuroimmunol       Date:  2016-09-01       Impact factor: 3.478

3.  Discovery of COVID-19 Inhibitors Targeting the SARS-CoV2 Nsp13 Helicase.

Authors:  Mark Andrew White; Wei Lin; Xiaodong Cheng
Journal:  bioRxiv       Date:  2020-08-10

4.  Discovery of COVID-19 Inhibitors Targeting the SARS-CoV-2 Nsp13 Helicase.

Authors:  Mark Andrew White; Wei Lin; Xiaodong Cheng
Journal:  J Phys Chem Lett       Date:  2020-10-14       Impact factor: 6.475

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.